Literature DB >> 30037448

The Cancer Emergency Department-The Ohio State University James Cancer Center Experience.

Luca R Delatore1.   

Abstract

In 2015, The James Cancer Hospital's Emergency Department (ED) opened at The Ohio State University Wexner Medical Center's ED. Careful planning was undertaken to assure that the needs of patients with cancer would be addressed. Strong relationships between experts in hematology, oncology, and emergency medicine were built to maximize the positive impact. Ongoing reevaluation of operational needs facilitates optimal patient flow, resource use, and opportunities to build and develop new resources. The results are evident in improved patient satisfaction in the cancer ED and a much smoother flow of patients into the system.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Administration; Emergency oncology; Hematology; Oncology emergency department

Mesh:

Year:  2018        PMID: 30037448     DOI: 10.1016/j.emc.2018.04.012

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  3 in total

1.  Arranging Hospice Care from the Emergency Department: A Single Center Retrospective Study.

Authors:  Rahul M Rege; Kelee Peyton; Sarah E Pajka; Corita R Grudzen; Mark J Conroy; Lauren T Southerland
Journal:  J Pain Symptom Manage       Date:  2021-08-17       Impact factor: 5.576

2.  A hybrid model of acute unscheduled cancer care provided by a hospital-based acute care clinic and the emergency department: a descriptive study.

Authors:  Jason J Bischof; Montika Bush; Rayad Bin Shams; Frances A Collichio; Timothy F Platts-Mills
Journal:  Support Care Cancer       Date:  2021-06-05       Impact factor: 3.603

3.  Impact of underlying malignancy on emergency department utilization and outcomes.

Authors:  Alexander S Qian; Edmund M Qiao; Vinit Nalawade; Rohith S Voora; Nikhil V Kotha; Christian Dameff; Christopher J Coyne; James D Murphy
Journal:  Cancer Med       Date:  2021-11-24       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.